Loading
Latest filing published 21 Jan 2026 for Cabaletta Bio, Inc., €22k. Read the official filing
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Mark Simon appears in our data through filings on Cabaletta Bio, Inc. shares, published by SEC (Form 4). In total, 2 filings cover trades dated from 18 October 2022 to 21 January 2026.
The open-market record is one-sided, with 2 purchases worth €138k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2026 to date brings 1 purchase and no sales.
The latest filing, published on 21 January 2026, reports an open-market purchase of €22k in Cabaletta Bio, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations